STAAR Surgical Co (STAA)

22.11 -1.25% (-0.28)

Over 5Y: -83.6%

2026-08-28
50 100 150
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q1 '23 — Revenue: 63.2M Q1 '23 — Operating Cash Flow: -4.6M Q1 '23 — Free Cash Flow: -7.1M Q1 '23 — Net Income: 9.6M Q2 '23 — Revenue: 81.1M Q2 '23 — Operating Cash Flow: 13.2M Q2 '23 — Free Cash Flow: 8M Q2 '23 — Net Income: 13M Q3 '23 — Revenue: 76M Q3 '23 — Revenue: 76M Q3 '23 — Operating Cash Flow: 24.1M Q3 '23 — Free Cash Flow: 17.8M Q3 '23 — Net Income: 10.3M Q4 '23 — Revenue: 19.1M Q4 '23 — Operating Cash Flow: 3M Q4 '23 — Free Cash Flow: -1.1M Q4 '23 — Net Income: 6.8M Q1 '24 — Net Income: 2.7M Q1 '24 — Revenue: 73.5M Q1 '24 — Operating Cash Flow: -5.1M Q1 '24 — Free Cash Flow: -8M Q1 '24 — Net Income: 2.7M Q2 '24 — Revenue: 92.3M Q2 '24 — Operating Cash Flow: -6.3M Q2 '24 — Free Cash Flow: -9.3M Q2 '24 — Net Income: 6.1M Q3 '24 — Revenue: 80.3M Q3 '24 — Operating Cash Flow: -6M Q3 '24 — Free Cash Flow: -15.2M Q3 '24 — Net Income: 4.8M Q4 '24 — Revenue: 76.3M Q4 '24 — Net Income: 7.8M Q1 '25 — Revenue: 77.4M Q1 '25 — Operating Cash Flow: 21.7M Q1 '25 — Free Cash Flow: 16.5M Q1 '25 — Net Income: -3.3M Q2 '25 — Revenue: 99M Q2 '25 — Operating Cash Flow: -10.4M Q2 '25 — Free Cash Flow: -16.6M Q2 '25 — Net Income: 7.4M Q3 '25 — Revenue: 88.6M Q3 '25 — Operating Cash Flow: 3.8M Q3 '25 — Free Cash Flow: -2.4M Q3 '25 — Net Income: 10M Q4 '25 — Revenue: 49M Q4 '25 — Operating Cash Flow: 642K Q4 '25 — Free Cash Flow: -5.1M Q4 '25 — Net Income: -34.2M Q1 '26 — Revenue: 42.6M Q1 '26 — Operating Cash Flow: -5.7M Q1 '26 — Free Cash Flow: -7.2M Q1 '26 — Net Income: -54.2M Q2 '26 — Revenue: 44.3M Q2 '26 — Operating Cash Flow: -27.2M Q2 '26 — Free Cash Flow: -29M Q2 '26 — Net Income: -16.8M Q3 '26 — Revenue: 94.7M Q3 '26 — Operating Cash Flow: 2.7M Q3 '26 — Free Cash Flow: 1.8M Q3 '26 — Net Income: 8.9M Q4 '26 — Revenue: 57.8M Q4 '26 — Operating Cash Flow: -3.9M Q4 '26 — Free Cash Flow: -5.6M Q4 '26 — Net Income: -18.3M Q1 '27 — Revenue: 93.5M Q1 '27 — Operating Cash Flow: -21.7M Q1 '27 — Free Cash Flow: -22.1M Q1 '27 — Net Income: 5.2M Q2 '27 — Revenue: 93.5M Q2 '27 — Operating Cash Flow: 19.7M Q2 '27 — Free Cash Flow: 19.2M Q2 '27 — Net Income: 8.1M -35M 0 35M 70M 105M
Q2 '23 Q4 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26 Q2 '27
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-07-03, reported in USD. The newest fact in the filings is dated 2026-07-03, 58 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.7
ROIC 5.9%
OE margin -10.3%
Gross margin 76.6%
Accruals 1.5%
ROA 0.81%
ROCE 3.4%
FCF margin -2.0%
OCF / EBIT -0.24×
OCF margin -0.96%
ROE 1.1%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Interest cover —
ND/EBITDA —
Cash runway 26.9 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 4.4×
F-score 1.1 pts
Cash / Debt —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.3
Sales/sh Y/Y +50.0%
Sales CAGR 4Y +0.96%
Sales Q/Q +111.0%
Shares change +0.89%
EBIT CAGR -28.2%
Div. growth —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.